Gsa Capital Partners LLP Zymeworks Inc. Transaction History

Gsa Capital Partners LLP

  • $1.32 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
SELL
$4.82 - $7.7 $222,438 - $355,347
-46,149 Closed
0 $0
Q1 2022

May 11, 2022
BUY
$6.0 - $16.98 $189,912 - $537,450
31,652 Added 218.33%
46,149 $302,000
Q4 2021

Feb 14, 2022
SELL
$15.19 - $29.33 $539,305 - $1.04 Million
-35,504 Reduced 71.01%
14,497 $238,000
Q3 2021

Nov 12, 2021
BUY
$27.35 - $37.28 $1.37 Million - $1.86 Million
50,001 New
50,001 $1.45 Million

Others Institutions Holding ZYME

# of Institutions
1
Shares Held
296K
Call Options Held
0
Put Options Held
0
View Full List

About Zymeworks Inc.

ZYME Quotes by TradingView
  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $949M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email